BioSpace News Archive

HealthTrackRx®, a clinical solutions company that assists healthcare providers with monitoring patients on prescription opioids, has now enrolled more than 30,000 patients in their GuideMed® program

Today through Sunday, Triller’s top creators develop content and engage with their communities to fundraise for the research of rare genetic diseases

Through Triple Play, Boys & Girls Clubs of America and the Anthem Blue Cross and Blue Shield Foundation are delivering education and programming that promote the importance of physical activity and proper nutrition, and enable youth to build the skills needed to overcome environmental factors that can negatively impact health and wellness.

The governing body of the not-for-profit Cold Spring Harbor Laboratory (CSHL) elected Dr. Marilyn Simons chair of the Board of Trustees on November 17, 2018.

Technavio analysts forecast the global cervical dilators market to have an incremental growth of USD 59.85 million during the forecast period, according to their latest market research report.

WellDyneRx, a full-service, independent Pharmacy Benefit Manager (PBM), is pleased to announce the launch of their Outsourced Pharmacy Solutions, a suite of turnkey pharmacy services that enable healthcare organizations to offer comprehensive clinical solutions that optimize patient care.

Danone North America announces it is awarding two graduate students $25,000 each for the 7th year in a row.

Data presented this week on wire-free radar breast localization demonstrated it may be a practical approach for positive axillary lymph node localization prior to neoadjuvant chemotherapy treatment (NAT) response.

Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, today announced that new data on its EndoPredict® test will be presented by academic collaborators at the San Antonio Breast Cancer Symposium.

Orchard Therapeutics (NASDAQ: ORTX), a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with serious and life-threatening rare diseases through innovative gene therapies, today announced the appointment of Alicia Secor to its board of directors